AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Memphasys

0.005

0.000

Volume:514.96K

Turnover:2K

Market Cap:15.44M

PE:-3.03

High:0.005

Open:0.005

Low:0.004

Close:0.005

52wk High:0.009

52wk Low:0.003

Shares:3.09B

Float Shares:1.79B

Volume Ratio:0.17

T/O Rate:0.03%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.002

EPS(LYR):-0.002

ROE:-95.94%

ROA:-16.65%

PB:3.66

PE(LYR):-3.03

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Memphasys Receives A$3.5 Million from Peters Investments

Memphasys - Receives A$3.5 Mln from Peters Investments Via Convertible Note Agreement

THOMSON REUTERS

Memphasys Targets Potentially Faster US Regulatory Approval Pathway for Sperm Separation System

MT Newswires Live

Memphasys Says Potential Expedited FDA Pathway to US IVF Market

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigershowtime.com/stock/MEM.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"MEM.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"MEM.AU\",,,,,undefined,":{"symbol":"MEM.AU","market":"AU","secType":"STK","nameCN":"Memphasys","latestPrice":0.005,"timestamp":1790835120000,"preClose":0.005,"halted":0,"volume":514955,"delay":0,"changeRate":0,"nameEN":"Memphasys","floatShares":1785112998,"shares":3087234000,"eps":-0.001648,"marketStatus":"Not Yet Opened","change":0,"latestTime":"10-01 16:12:00 AEST","open":0.005,"high":0.005,"low":0.004,"amount":2289,"amplitude":0.2,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.001648,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1790899200000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.005,"openAndCloseTimeList":[[1790812800000,1790834400000]],"volumeRatio":0.1671720356368643,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"MEM.AU","preClose":0.005,"auctionPrice":0.005,"auctionVolume":50000,"auctionTime":1790888451840,"referenceTime":1790850603090,"auction":1,"marketStatus":"盘前竞价","timestamp":1790888451840}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"MEM.AU\",,,,,undefined,":{"symbol":"MEM.AU","floatShares":1785112998,"roa":"-16.65%","roe":"-95.94%","lyrEps":-0.001648,"volumeRatio":0.1671720356368643,"shares":3087234000,"dividePrice":0,"high":0.005,"amplitude":0.2,"preClose":0.005,"low":0.004,"week52Low":0.003,"pbRate":"3.66","psRate":"23.46","week52High":0.009,"institutionHeld":0,"latestPrice":0.005,"eps":-0.001648,"divideRate":0,"volume":514955,"delay":0,"ttmEps":-0.001648,"open":0.005,"prevYearClose":0.007,"prevWeekClose":0.005,"prevMonthClose":0.005,"prevQuarterClose":0.005,"fiveDayClose":0.005,"twentyDayClose":0.006,"sixtyDayClose":0.008,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MEM.AU\",params:#limit:5,,,undefined,":[{"date":"2022-09-01","symbol":"MEM.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1661990400000,"name":null,"time":"","dateTimestamp":1661954400000,"actualEps":null},{"market":"AU","date":"2022-08-23","symbol":"MEM.AU","defaultRemindTime":1661212800000,"type":"split","dateTimestamp":1661176800000,"forFactor":954054,"toFactor":1000000,"ratio":0.954054}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MEM.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MEM.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2671726140","title":"Memphasys Receives A$3.5 Million from Peters Investments","url":"https://stock-news.laohu8.com/highlight/detail?id=2671726140","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671726140?lang=en_us&edition=fundamental","pubTime":"2026-09-29 09:33","pubTimestamp":1790645610,"startTime":"0","endTime":"0","summary":"BRIEF-Memphasys Receives A$3.5 Million From Peters InvestmentsSept 29 (Reuters)-Memphasys LtdMEM.AX:MEMPHASYS RECEIVES A$3.5 MILLION FROM PETERS INVESTMENTSRECEIVES A$3.5 MILLION FROM PETERS INVESTMENTS VIA CONVERTIBLE NOTE AGREEMENTFurther company coverage:MEM.AX","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nFWN45K0GM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7048","MEM.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671226515","title":"Memphasys - Receives A$3.5 Mln from Peters Investments Via Convertible Note Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2671226515","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671226515?lang=en_us&edition=fundamental","pubTime":"2026-09-29 07:44","pubTimestamp":1790639058,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nFWN45K0GM:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7048","MEM.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670092414","title":"Memphasys Targets Potentially Faster US Regulatory Approval Pathway for Sperm Separation System","url":"https://stock-news.laohu8.com/highlight/detail?id=2670092414","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670092414?lang=en_us&edition=fundamental","pubTime":"2026-09-25 10:46","pubTimestamp":1790304377,"startTime":"0","endTime":"0","summary":"Memphasys  said a reassessment of its US regulatory strategy for the Felix sperm separation system identified a potentially faster, cost effective, and more direct pathway toward US Food and Drug Administration  clearance, according to a Friday filing with the Australian bourse.The company, which was previously contemplating the more complex De Novo pathway for Felix, said it identified a medical device it believes may provide an appropriate predicate, potentially allowing the device  to pursue the FDA's more established 510 clearance pathway.Memphasys will now engage with the FDA to seek feedback on the proposed pathway before proceeding to a formal submission, it said.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MEM.AU","BK4588","BK7048","BK4585","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670841194","title":"Memphasys Says Potential Expedited FDA Pathway to US IVF Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2670841194","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670841194?lang=en_us&edition=fundamental","pubTime":"2026-09-25 09:22","pubTimestamp":1790299332,"startTime":"0","endTime":"0","summary":"Sept 25 (Reuters) - Memphasys Ltd::*POTENTIAL EXPEDITED FDA PATHWAY TO US IVF MARKET*BOARD IDENTIFIES POTENTIAL EXPEDITED FDA PATHWAY FOR FELIX REPLACING DE NOVO*TO UNDERTAKE PRE-SUBMISSION ENGAGEMENT","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260925:nRSD248nc8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEM.AU","BK7048"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":11,"pageCount":1,"totalSize":41,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/MEM.AU\",params:#limit:6,delay:true,,,undefined,":[]}}